# FDA Inspection 1262166 - Jilhare Devendra Annaji - January 31, 2025

Source: https://www.keypedia.com/records/fda_inspections/jilhare-devendra-annaji/6fd240f2-dd9f-48f5-be94-eac3118678d0
Source feed: FDA_Inspections

> FDA Inspection 1262166 for Jilhare Devendra Annaji on January 31, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1262166
- Company Name: Jilhare Devendra Annaji
- Inspection Date: 2025-01-31
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1262166 - 2025-01-31](https://www.keypedia.com/records/fda_inspections/jilhare-devendra-annaji/8697b24c-a192-4ff9-95d0-9b5ed142c0e7)

Company: https://www.keypedia.com/companies/jilhare-devendra-annaji/dcbacc21-4669-4424-9677-b909994b64f9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c